Research programme: cancer therapeutics - Cleave BiosciencesAlternative Names: Inhibitors of p97 ATPase activity - Cleave Biosciences; p97 inhibitors - Cleave Biosciences
Latest Information Update: 07 Nov 2013
At a glance
- Originator Cleave Biosciences
- Class Small molecules
- Mechanism of Action Adenosine triphosphatase inhibitors; Protein modulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Cancer